Boston scientific received information that the patient implanted with this cardiac resynchronization therapy defibrillator (crt-d) was to undergo an mri.Testing was performed and it was deemed that the patient's intrinsic rhythm was acceptable to undergo the procedure.The crt-d was programmed to mri protection mode prior to mri exposure.Before the mri scan was conducted, the patient became asystolic and required cardiopulmonary resuscitation (cpr).The crt-d was reprogrammed out of mri protection mode and the patient recovered fully.The patient was reported to suffer from intermittent complete atrioventricular (av) block and was hospitalized.The patient was discharged at a later date and the crt-d remains in service.No additional adverse patient effects were reported.Although the crt-d is approved for sale in (b)(6), the software that includes the mri protection mode feature is under clinical trial investigation.This feature, when enabled, suspends bradycardia therapy during the mri scan.This is communicated in the device labeling.Based on the observations, it is likely that the event was due to a previously unrecognized intermittent third degree av block resulting in transient pacemaker dependency.It was confirmed that a future mri scan will not be performed due to these recent changes in the patient's condition.
|